Juvenile ankylosing spondylitis (JAS) is a type of arthritis that affects the spine and the sites where the muscles, tendons, and ligaments are attached to bone. "Ankylosing" means stiff or rigid, "spondyl" means spine, and "itis" refers to inflammation.
JAS causes inflammation of the spine and large joints, resulting in stiffness and pain. The disease may result in:
JAS is one of four disorders classified as spondyloarthropathies. The others are psoriatic arthritis, inflammatory bowel disease, and Reiter's syndrome. These disorders share features such as:
Symptoms of JAS tend to occur and disappear over periods of time. While each child may experience symptoms differently, some of the most common include:
Symptoms of juvenile ankylosing spondylitis may resemble other medical conditions or problems. Always consult your child's physician for a diagnosis.
JAS is considered to be a multifactorial condition, meaning that "many factors" are involved in causing it.
There is a group of genes called HLA antigens that play a major role in whether your child will get a certain disease. The HLA antigen associated with JAS is called B27.
If your child has HLA-B27, she may have a genetic susceptibility (increased chance) of developing JAS. But it's important to remember that while most people with JAS do have HLA-B27, only a few people with HLA-B27 ever actually have JAS. This means your child may test positive for HLA-B27, but not have JAS.
In addition to a complete medical history and physical examination, some of the diagnostic tests your child's doctor may order include:
The goal of treatment for JAS is to reduce pain and stiffness, prevent deformities, and help your child maintain as normal and active a lifestyle as possible.
Components of your child's treatment may include:
The Rheumatology Program at Boston Children's Hospital cares for children and adolescents with a broad range of rheumatologic and inflammatory diseases, including juvenile ankylosing spondylitis. As one of the largest and most experienced rheumatology programs in the United States, we see more than 3,000 children in our outpatient clinic each year. More than 600 children are treated on an inpatient (hospitalized) basis each year.